Study title: efficacy and tolerance of two galenical product formulations of canesten vaginal tablets containing 500 mg of the active ingredient clotrimazole after a single administration to patients with vaginal yeast infections
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Bacterial Infections and Mycoses [C01] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: CLOTRIMAZOLE | |||||
ATC code: | |||||
Document link: Bayer CC_Clotrimazole_0444_study_synopsis.pdf | |||||
Document date: 2011-09-13 | |||||
Study number: Study 0444 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |